Back to Search
Start Over
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.
- Source :
-
EMBO molecular medicine [EMBO Mol Med] 2017 Jul; Vol. 9 (7), pp. 985. - Publication Year :
- 2017
Details
- Language :
- English
- ISSN :
- 1757-4684
- Volume :
- 9
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- EMBO molecular medicine
- Publication Type :
- Academic Journal
- Accession number :
- 28533211
- Full Text :
- https://doi.org/10.15252/emmm.201707895